ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
Cash from Operating Activities
ASKA Pharmaceutical Holdings Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
114%
|
CAGR 10-Years
N/A
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Operating Activities
¥731.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
17%
|
CAGR 10-Years
13%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Operating Activities
¥595.3B
|
CAGR 3-Years
47%
|
CAGR 5-Years
47%
|
CAGR 10-Years
25%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Operating Activities
¥283.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Operating Activities
¥409.9B
|
CAGR 3-Years
26%
|
CAGR 5-Years
28%
|
CAGR 10-Years
23%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Operating Activities
¥216.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-2%
|
See Also
What is ASKA Pharmaceutical Holdings Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
3.4B
JPY
Based on the financial report for Mar 31, 2023, ASKA Pharmaceutical Holdings Co Ltd's Cash from Operating Activities amounts to 3.4B JPY.
What is ASKA Pharmaceutical Holdings Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
114%
Over the last year, the Cash from Operating Activities growth was 18%.